Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer
B Fisher and EP Mamounas
JCO Mar 1 1995: 537–540. [PDF]
Current approaches to hematopoietic stem-cell purging in chronic myeloid leukemia
SG O'Brien and JM Goldman
JCO Mar 1 1995: 541–546. [PDF]
	Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
	TJ Powles, TF Hickish, A Makris, SE Ashley, ME O'Brien, VA Tidy, S Casey, AG Nash, N Sacks, and D Cosgrove
	JCO Mar 1 1995: 547–552. [Abstract] [PDF]
	Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy
	HM Kantarjian, M Talpaz, J Hester, E Feldman, M Korbling, J Liang, MB Rios, TL Smith, L Calvert, and AB Deisseroth
	JCO Mar 1 1995: 553–559. [Abstract] [PDF]
	Improved survival for patients with acute myelogenous leukemia
	AJ Mitus, KB Miller, DP Schenkein, HF Ryan, SK Parsons, C Wheeler, and JH Antin
	JCO Mar 1 1995: 560–569. [Abstract] [PDF]
	2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia
	A Saven, RH Lemon, M Kosty, E Beutler, and LD Piro
	JCO Mar 1 1995: 570–574. [Abstract] [PDF]
	Serum interleukin-6 levels correlate with prognosis in diffuse large- cell lymphoma
	JF Seymour, M Talpaz, F Cabanillas, M Wetzler, and R Kurzrock
	JCO Mar 1 1995: 575–582. [Abstract] [PDF]
	Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma
	A Younes, A Sarris, A Melnyk, J Romaguera, P McLaughlin, F Swan, MA Rodriguez, F Hagemeister, D Moore, and L North
	JCO Mar 1 1995: 583–587. [Abstract] [PDF]
	BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma
	W Mills, R Chopra, A McMillan, R Pearce, DC Linch, and AH Goldstone
	JCO Mar 1 1995: 588–595. [Abstract] [PDF]
	High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy
	T Demirer, CH Weaver, CD Buckner, FB Petersen, WI Bensinger, J Sanders, RA Clift, K Lilleby, C Anasetti, and P Martin
	JCO Mar 1 1995: 596–602. [Abstract] [PDF]
	Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease
	O Beaty, 3rd, MM Hudson, C Greenwald, X Luo, L Fang, JA Wilimas, EI Thompson, LE Kun, and CB Pratt
	JCO Mar 1 1995: 603–609. [Abstract] [PDF]
	The Third Intergroup Rhabdomyosarcoma Study
	W Crist, EA Gehan, AH Ragab, PS Dickman, SS Donaldson, C Fryer, D Hammond, DM Hays, J Herrmann, and R Heyn
	JCO Mar 1 1995: 610–630. [Abstract] [PDF]
	Use of intracavitary cisplatin for the treatment of childhood solid tumors in the chest or abdominal cavity
	MW Boyer, CL Moertel, JR Priest, and WG Woods
	JCO Mar 1 1995: 631–636. [Abstract] [PDF]
	Multicenter phase II study of weekly oral vinorelbine for stage IV non- small-cell lung cancer
	EE Vokes, RK Rosenberg, M Jahanzeb, JB Craig, RJ Gralla, CP Belani, SE Jones, JW Bigley, and JA Hohneker
	JCO Mar 1 1995: 637–644. [Abstract] [PDF]
	Phase II study of docetaxel for advanced or metastatic platinum- refractory non-small-cell lung cancer
	FV Fossella, JS Lee, DM Shin, M Calayag, M Huber, R Perez-Soler, WK Murphy, S Lippman, S Benner, and B Glisson
	JCO Mar 1 1995: 645–651. [Abstract] [PDF]
	Can cytotoxic dose-intensity be increased by using granulocyte colony- stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer
	PJ Woll, J Hodgetts, L Lomax, F Bildet, V Cour-Chabernaud, and N Thatcher
	JCO Mar 1 1995: 652–659. [Abstract] [PDF]
	Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
	PE Postmus, EF Smit, H Haaxma-Reiche, N van Zandwijk, A Ardizzoni, E Quoix, A Kirkpatrick, T Sahmoud, and G Giaccone
	JCO Mar 1 1995: 660–665. [Abstract] [PDF]
	Treatment outcome and prognostic factors for primary nasal lymphoma
	R Liang, D Todd, TK Chan, E Chiu, A Lie, YL Kwong, D Choy, and FC Ho
	JCO Mar 1 1995: 666–670. [Abstract] [PDF]
	Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation
	DG Pfister, LB Harrison, EW Strong, JP Shah, RW Spiro, DH Kraus, JG Armstrong, MJ Zelefsky, DE Fass, and MH Weiss
	JCO Mar 1 1995: 671–680. [Abstract] [PDF]
	Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy
	LX Cubeddu, DT O'Connor, and RJ Parmer
	JCO Mar 1 1995: 681–687. [Abstract] [PDF]
	Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
	G Fyfe, RI Fisher, SA Rosenberg, M Sznol, DR Parkinson, and AC Louie
	JCO Mar 1 1995: 688–696. [Abstract] [PDF]
	Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer
	R Silvestrini, MG Daidone, A Luisi, P Boracchi, M Mezzetti, G Di Fronzo, S Andreola, B Salvadori, and U Veronesi
	JCO Mar 1 1995: 697–704. [Abstract] [PDF]
	Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization
	JL Passos-Coelho, HG Braine, JM Davis, AM Huelskamp, KG Schepers, K Ohly, B Clarke, SK Wright, SJ Noga, and NE Davidson
	JCO Mar 1 1995: 705–714. [Abstract] [PDF]
	Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment
	P Sparen, L Gustafsson, LG Friberg, J Ponten, R Bergstrom, and HO Adami
	JCO Mar 1 1995: 715–725. [Abstract] [PDF]
	Impact of doxorubicin on survival in advanced ovarian cancer
	RP A'Hern and ME Gore
	JCO Mar 1 1995: 726–732. [Abstract] [PDF]
	Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial
	GJ Veldhuis, PH Willemse, MM van Gameren, JG Aalders, NH Mulder, B Mull, B Biesma, and EG de Vries
	JCO Mar 1 1995: 733–740. [Abstract] [PDF]
	Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study
	MJ Ratain, G Rosner, SL Allen, M Costanza, DA Van Echo, IC Henderson, and RL Schilsky
	JCO Mar 1 1995: 741–747. [Abstract] [PDF]
	Pain and depression in patients with newly diagnosed pancreas cancer
	DP Kelsen, RK Portenoy, HT Thaler, D Niedzwiecki, SD Passik, Y Tao, W Banks, MF Brennan, and KM Foley
	JCO Mar 1 1995: 748–755. [Abstract] [PDF]
	Survey of the provision of supportive care services at National Cancer Institute-designated cancer centers
	PH Coluzzi, M Grant, JH Doroshow, M Rhiner, B Ferrell, and L Rivera
	JCO Mar 1 1995: 756–764. [Abstract] [PDF]
	Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool
	G Gasparini and AL Harris
	JCO Mar 1 1995: 765–782. [Abstract] [PDF]
	Ovarian cancer screening
	SE Mackey and WT Creasman
	JCO Mar 1 1995: 783–793. [Abstract] [PDF]
Combination chemotherapy with tetracycline and aggressive supportive care for immunoproliferative small-intestinal disease lymphoma
NS el Saghir
JCO Mar 1 1995: 794–795. [PDF]
Polymerase chain reaction monitoring for bcl-2 can be a dependable test under the right conditions
F Cabanillas and MS Lee
JCO Mar 1 1995: 795–796. [PDF]
Combination chemotherapy of metastatic melanoma
D Berd and MJ Mastrangelo
JCO Mar 1 1995: 796–797. [PDF]
Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancer
CD Atkins
JCO Mar 1 1995: 797a. [PDF]
The price of success
SM Grunberg, H Burris, 3rd, and R Livingston
JCO Mar 1 1995: 797b–798. [PDF]
Radiotherapy still has a major role in the management of localized orbital rhabdomyosarcoma
JE Kingston, PN Plowman, and J Wright
JCO Mar 1 1995: 798–799. [PDF]
Reviving the pelvic examination for evaluating the status of ovarian carcinoma
VL Seewaldt, JM Cain, BE Greer, HK Tamimi, DC Figge, and RB Livingston
JCO Mar 1 1995: 799. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.